Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription

Articles published in JAMA

Retrieve available abstracts of 26 articles:
HTML format
Text format

Single Articles

    August 2016
  1. KAZI DS, Moran AE, Coxson PG, Penko J, et al
    Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
    JAMA. 2016;316:743-53.
    PubMed     Text format     Abstract available

  2. LOZANO P, Henrikson NB, Dunn J, Morrison CC, et al
    Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2016;316:645-55.
    PubMed     Text format     Abstract available

  3. BIBBINS-DOMINGO K, Grossman DC, Curry SJ, Davidson KW, et al
    Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2016;316:625-33.
    PubMed     Text format     Abstract available

  4. URBINA EM, de Ferranti SD
    Lipid Screening in Children and Adolescents.
    JAMA. 2016;316:589-91.
    PubMed     Text format    

    April 2016
  5. NISSEN SE, Stroes E, Dent-Acosta RE, Rosenson RS, et al
    Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
    JAMA. 2016;315:1580-90.
    PubMed     Text format     Abstract available

  6. WATERS DD, Hsue PY, Bangalore S
    PCSK9 Inhibitors for Statin Intolerance?
    JAMA. 2016;315:1571-2.
    PubMed     Text format    

    March 2016
  7. SHRANK WH, Barlow J
    New Strategies to Treat High Cholesterol--Reply.
    JAMA. 2016;315:1169-70.
    PubMed     Text format    

  8. BLUM CB, Stone NJ
    New Strategies to Treat High Cholesterol.
    JAMA. 2016;315:1169.
    PubMed     Text format    

    December 2015
  9. JIN J
    JAMA PATIENT PAGE. PCSK9 Inhibitors for Treating High Cholesterol.
    JAMA. 2015;314:2320.
    PubMed     Text format    

    November 2015
  10. PURSNANI A, Massaro JM, Hoffmann U
    Predicted vs Observed Clinical Event Risk for Cardiovascular Disease-Reply.
    JAMA. 2015;314:2082-2083.
    PubMed     Text format    

    Predicted vs Observed Clinical Event Risk for Cardiovascular Disease.
    JAMA. 2015;314:2082.
    PubMed     Text format    

    October 2015
  12. SHRANK WH, Barlow JF, Brennan TA
    New Therapies in the Treatment of High Cholesterol: An Argument to Return to Goal-Based Lipid Guidelines.
    JAMA. 2015;314:1443-4.
    PubMed     Text format    

  13. GANDA OP
    Failure to Report Financial Disclosure Information.
    JAMA. 2015;314:1404.
    PubMed     Text format    

    July 2015
  14. MITKA M
    Exploring Statins to Decrease HIV-Related Heart Disease Risk.
    JAMA. 2015 Jul 29. doi: 10.1001/jama.2015.5498.
    PubMed     Text format    

  15. PURSNANI A, Massaro JM, D'Agostino RB Sr, O'Donnell CJ, et al
    Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    JAMA. 2015;314:134-41.
    PubMed     Text format     Abstract available

  16. GREENLAND P, Lauer MS
    Cholesterol Lowering in 2015: Still Answering Questions About How and in Whom.
    JAMA. 2015;314:127-8.
    PubMed     Text format    

    June 2015
  17. GANDA OP
    Clinician Understanding of Cholesterol Treatment Guidelines--Reply.
    JAMA. 2015;313:2382.
    PubMed     Text format    

  18. LEE TC, McDonald EG
    Clinician Understanding of Cholesterol Treatment Guidelines.
    JAMA. 2015;313:2381-2.
    PubMed     Text format    

    March 2015
  19. BESSELING J, Kastelein JJ, Defesche JC, Hutten BA, et al
    Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.
    JAMA. 2015;313:1029-36.
    PubMed     Text format     Abstract available

  20. PREISS D, Sattar N
    Does the LDL receptor play a role in the risk of developing type 2 diabetes?
    JAMA. 2015;313:1016-7.
    PubMed     Text format    

  21. GANDA OP
    Deciphering cholesterol treatment guidelines: a clinician's perspective.
    JAMA. 2015;313:1009-10.
    PubMed     Text format    

  22. STINE N, Chokshi D
    Multifactorial risk assessment for atherosclerotic cardiovascular disease--reply.
    JAMA. 2015;313:972.
    PubMed     Text format    

    Multifactorial risk assessment for atherosclerotic cardiovascular disease.
    JAMA. 2015;313:971-2.
    PubMed     Text format    

    January 2015
  24. RECORD NB, Onion DK, Prior RE, Dixon DC, et al
    Community-wide cardiovascular disease prevention programs and health outcomes in a rural county, 1970-2010.
    JAMA. 2015;313:147-55.
    PubMed     Text format     Abstract available

  25. LABARTHE DR, Stamler J
    Improving cardiovascular health in a rural population: can other communities do the same?
    JAMA. 2015;313:139-40.
    PubMed     Text format    

    November 2014
  26. STINE NW, Chokshi DA
    Elimination of lipid levels from quality measures: implications and alternatives.
    JAMA. 2014;312:1971-2.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.